We are live on ! Find out more
PCA

Personal Capital Advisors Portfolio holdings

AUM $20.6B
1-Year Est. Return 13.65%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
-13.65%
3 Year Est. Return
+17.55%
5 Year Est. Return
+33.04%
10 Year Est. Return
AUM
$13.3B
AUM Growth
+$1.16B
Cap. Flow
+$456M
Cap. Flow %
3.44%
Top 10 Hldgs %
44.23%
Holding
423
New
61
Increased
243
Reduced
94
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 6.1%
2 Consumer Discretionary 4.27%
3 Communication Services 4.08%
4 Materials 3.87%
5 Consumer Staples 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USMV icon
401
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
$202K ﹤0.01%
+3,163
New +$201K
PCG icon
402
PG&E
PCG
$38.4B
$189K ﹤0.01%
+20,169
New +$187K
SIRI icon
403
SiriusXM
SIRI
$10.2B
$183K ﹤0.01%
3,417
-66
-2% -$3.79K
FSKR
404
DELISTED
FS KKR Capital Corp. II
FSKR
$181K ﹤0.01%
12,287
-588
-5% -$8.41K
EPD icon
405
Enterprise Products Partners
EPD
$81.9B
$172K ﹤0.01%
10,894
-2,610
-19% -$45.7K
GE icon
406
GE Aerospace
GE
$383B
$168K ﹤0.01%
5,400
+1,234
+30% +$40.1K
HAL icon
407
Halliburton
HAL
$26.6B
$168K ﹤0.01%
13,932
+321
+2% +$4.65K
HPE icon
408
Hewlett Packard
HPE
$66.5B
$154K ﹤0.01%
16,481
+3,182
+24% +$30.4K
F icon
409
Ford
F
$57.5B
$109K ﹤0.01%
16,379
+6,318
+63% +$42.8K
SABA
410
Saba Capital Income & Opportunities Fund II
SABA
$221M
$93K ﹤0.01%
+8,685
New +$93.8K
MRKR icon
411
Marker Therapeutics
MRKR
$20.3M
$39K ﹤0.01%
2,571
ATHX
412
DELISTED
Athersys, Inc. Common Stock
ATHX
$39K ﹤0.01%
800
QEP
413
DELISTED
QEP RESOURCES, INC.
QEP
$22K ﹤0.01%
23,943
+3,357
+16% +$4.38K
TXMD icon
414
TherapeuticsMD
TXMD
$23.6M
$21K ﹤0.01%
260
MNKD icon
415
MannKind Corp
MNKD
$1.17B
$20K ﹤0.01%
10,530
LYG icon
416
Lloyds Banking Group
LYG
$90.8B
$16K ﹤0.01%
+12,066
New +$16.9K
CRVO icon
417
CervoMed
CRVO
$24.1M
$8K ﹤0.01%
+133
New +$10.1K
UAMY icon
418
United States Antimony
UAMY
$839M
$4K ﹤0.01%
+15,000
New +$6.84K
FMC icon
419
FMC
FMC
$1.3B
-3,010
Closed -$300K
GS icon
420
Goldman Sachs
GS
$303B
-1,136
Closed -$224K
IWR icon
421
iShares Russell Mid-Cap ETF
IWR
$56.3B
-3,852
Closed -$206K
RCUS icon
422
Arcus Biosciences
RCUS
$3.47B
-9,395
Closed -$232K
VISL
423
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
-104
Closed -$8K

Similar funds

Personal Capital Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Personal Capital Advisors held 423 positions worth $13.3B, up 9.6% from $12.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Personal Capital Advisors deployed $456M of net new capital in Q3 2020, opening 61 new positions and adding to 243 existing holdings. Its largest new stake was Roper Technologies: 103,099 shares worth $40.7M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.6% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Vanguard Morningstar Small-Cap Value ETF, an estimated $137M trimmed.

  • Personal Capital Advisors's largest Q3 2020 buy was Roper Technologies: 103,099 shares worth $40.7M.
  • Personal Capital Advisors added most to Vanguard Short-Term Bond ETF in Q3 2020, an estimated $73.5M increase.
  • Personal Capital Advisors's biggest Q3 2020 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $137M.
  • Personal Capital Advisors fully exited FMC in Q3 2020, selling an estimated $300K.
  • Personal Capital Advisors's ten largest holdings make up 44% of its $13.3B portfolio in Q3 2020.
  • Personal Capital Advisors opened 61 new positions and closed 5 in Q3 2020.
  • Personal Capital Advisors's portfolio value rose 9.6% quarter-over-quarter to $13.3B.

Based on Personal Capital Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.